362 related articles for article (PubMed ID: 14687914)
21. Progression of joint damage despite control of inflammation in rheumatoid arthritis: a role for cartilage damage driven synovial fibroblast activity.
Lafeber FP; Van der Laan WH
Ann Rheum Dis; 2012 Jun; 71(6):793-5. PubMed ID: 22566404
[No Abstract] [Full Text] [Related]
22. Pathogenesis of rheumatoid arthritis.
Weyand CM; Goronzy JJ
Med Clin North Am; 1997 Jan; 81(1):29-55. PubMed ID: 9012754
[TBL] [Abstract][Full Text] [Related]
23. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.
Tanida S; Yoshitomi H; Ishikawa M; Kasahara T; Murata K; Shibuya H; Ito H; Nakamura T
Cytokine; 2011 Aug; 55(2):237-44. PubMed ID: 21592822
[TBL] [Abstract][Full Text] [Related]
24. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
[TBL] [Abstract][Full Text] [Related]
25. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of an equine model of synovitis-induced arthritis.
Todhunter PG; Kincaid SA; Todhunter RJ; Kammermann JR; Johnstone B; Baird AN; Hanson RR; Wright JM; Lin HC; Purohit RC
Am J Vet Res; 1996 Jul; 57(7):1080-93. PubMed ID: 8807026
[TBL] [Abstract][Full Text] [Related]
27. TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation.
van Hamburg JP; Asmawidjaja PS; Davelaar N; Mus AM; Cornelissen F; van Leeuwen JP; Hazes JM; Dolhain RJ; Bakx PA; Colin EM; Lubberts E
Ann Rheum Dis; 2012 Apr; 71(4):606-12. PubMed ID: 22219138
[TBL] [Abstract][Full Text] [Related]
28. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.
Noss EH; Brenner MB
Immunol Rev; 2008 Jun; 223():252-70. PubMed ID: 18613841
[TBL] [Abstract][Full Text] [Related]
29. Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis.
Rana AK; Li Y; Dang Q; Yang F
Int Immunopharmacol; 2018 Dec; 65():348-359. PubMed ID: 30366278
[TBL] [Abstract][Full Text] [Related]
30. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S
Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156
[TBL] [Abstract][Full Text] [Related]
31. [An unwelcome host in the pathogenesis of arthritides].
Lapadula G; Iannone F
Reumatismo; 2003; 55(2):71-4. PubMed ID: 12874639
[No Abstract] [Full Text] [Related]
32. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
Miossec P
Arthritis Rheum; 2003 Mar; 48(3):594-601. PubMed ID: 12632409
[No Abstract] [Full Text] [Related]
33. Rheumatoid arthritis progression mediated by activated synovial fibroblasts.
Neumann E; Lefèvre S; Zimmermann B; Gay S; Müller-Ladner U
Trends Mol Med; 2010 Oct; 16(10):458-68. PubMed ID: 20739221
[TBL] [Abstract][Full Text] [Related]
34. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis.
Schedel J; Gay RE; Kuenzler P; Seemayer C; Simmen B; Michel BA; Gay S
Arthritis Rheum; 2002 Jun; 46(6):1512-8. PubMed ID: 12115181
[TBL] [Abstract][Full Text] [Related]
35. [Role of hypoxia-inducible factor in the pathogenesis of rheumatoid arthritis].
Yu RH; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1095-1099. PubMed ID: 27987521
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol Alleviates Rheumatoid Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling Pathways, and Suppressing Angiogenesis.
Yang G; Chang CC; Yang Y; Yuan L; Xu L; Ho CT; Li S
J Agric Food Chem; 2018 Dec; 66(49):12953-12960. PubMed ID: 30511573
[TBL] [Abstract][Full Text] [Related]
37. Joint destruction in rheumatoid arthritis: biological bases.
Kingsley G; Panayi GS
Clin Exp Rheumatol; 1997; 15 Suppl 17():S3-14. PubMed ID: 9266128
[TBL] [Abstract][Full Text] [Related]
38. [Pathology and progression of intra-articular inflammation in rheumatoid arthritis].
Geiler G
Verh Dtsch Ges Pathol; 1996; 80():46-57. PubMed ID: 9065054
[TBL] [Abstract][Full Text] [Related]
39. The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis.
Neumann E; Hasseli R; Lange U; Müller-Ladner U
Curr Pharm Biotechnol; 2018; 19(15):1182-1188. PubMed ID: 30605055
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11.
Chang SK; Gu Z; Brenner MB
Immunol Rev; 2010 Jan; 233(1):256-66. PubMed ID: 20193004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
